These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28942872)

  • 21. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
    Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
    Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation.
    Watanabe T; Takeishi Y; Hirono O; Itoh M; Matsui M; Nakamura K; Tamada Y; Kubota I
    Heart Vessels; 2005 Mar; 20(2):45-9. PubMed ID: 15772777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis.
    Horjen AW; Ulimoen SR; Norseth J; Svendsen JH; Smith P; Arnesen H; Seljeflot I; Tveit A
    Scand J Clin Lab Invest; 2018 Sep; 78(5):386-392. PubMed ID: 29933716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein, left atrial volume, and atrial fibrillation: a prospective study in high-risk elderly.
    Casaclang-Verzosa G; Barnes ME; Blume G; Seward JB; Gersh BJ; Cha SS; Bailey KR; Tsang TS
    Echocardiography; 2010 Apr; 27(4):394-9. PubMed ID: 20070356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
    Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
    Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction.
    Bas HA; Aksoy F; Icli A; Varol E; Dogan A; Erdogan D; Ersoy I; Arslan A; Ari H; Bas N; Sutcu R; Ozaydin M
    Scand J Clin Lab Invest; 2017 Apr; 77(2):77-82. PubMed ID: 27905214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
    Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of postoperative atrial fibrillation in patients with coronary artery disease undergoing cardiopulmonary bypass: a possible role for myocardial ischemia and atrial inflammation.
    Narducci ML; Pelargonio G; Rio T; Leo M; Di Monaco A; Musaico F; Pazzano V; Trotta F; Liuzzo G; Severino A; Biasucci LM; Scapigliati A; Glieca F; Cavaliere F; Rebuzzi AG; Massetti M; Crea F
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):512-9. PubMed ID: 24094564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of serum sST2 and sCD40L values in patients with microvascular angina.
    Aslan G; Polat V; Bozcali E; Opan S; Çetin N; Ural D
    Microvasc Res; 2019 Mar; 122():85-93. PubMed ID: 30502363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome, high-sensitivity C-reactive protein levels and the risk of new-onset atrial fibrillation: Results from the Kailuan Study.
    Wang Z; Wang B; Li X; Zhang S; Wu S; Xia Y
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):102-109. PubMed ID: 33500102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships of High-sensitive C-reactive Protein and P-wave Dispersion in Lone Atrial Fibrillation.
    Zheng LH; Yao Y; Wu LM; Zhang KJ; Zhang S
    Chin Med J (Engl); 2015 Jun; 128(11):1450-4. PubMed ID: 26021499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble sST2 biomarker analysis for fibrosis development in atrial fibrillation. A case control study.
    Marino L; Romano GP; Santulli M; Bertazzoni G; Suppa M
    Clin Ter; 2021 Mar; 172(2):145-150. PubMed ID: 33763675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
    Sezai A; Nakai T; Hata M; Yoshitake I; Shiono M; Kunimoto S; Hirayama A
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1241-8. PubMed ID: 22858430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-sensitivity cardiac troponin I and risk of incident atrial fibrillation hospitalisation in an Australian community-based cohort: The Busselton health study.
    Zhu K; Hung J; Divitini M; Murray K; Lim EM; St John A; Walsh JP; Knuiman M
    Clin Biochem; 2018 Aug; 58():20-25. PubMed ID: 29746826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation.
    Wang Z; Cheng L; Zhang J; Liang Z; Dong R; Hang F; Wang X; Wang Z; Wu Y; Du J
    Med Sci Monit; 2020 Sep; 26():e926221. PubMed ID: 32898129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
    Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic high-sensitivity troponin elevations in atrial fibrillation patients might not be associated with significant coronary artery disease.
    Thelin J; Melander O
    BMC Cardiovasc Disord; 2017 Jun; 17(1):169. PubMed ID: 28655300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.